Editor - Salvador Ventura | Autonomous University of Barcelona | 5197
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Salvador Ventura

Salvador Ventura
Salvador Ventura
Associate Professor
Dep. of Biochemistry and Molecular Biology
Autonomous University of Barcelona


Cordoba, 1967. Salvador Ventura is Associate Prof. at the Dep. of Biochemistry and Molecular Biology and leader of the Protein Folding and Design group at the Institute of Biotechnology and Biomedicine, Autonomous University of Barcelona (UAB). He has authored more than 80 peer-reviewed research and review papers on protein folding and proteomics, apart from several book chapters and patents. He got his Ph. D. in Biology at the UAB in 1998 and worked as postdoctoral fellow (1999-2001) at EMBL-Heidelberg under the supervision of Dr.Luis Serrano. He has been researcher at Harvard Medical School (USA) andKarolinska Institutet (Sweden) among other centres. He rejoined UAB as a Ramon y Cajal researcher in 2003. Dr. Ventura received the UAB 2008 Excellence Research Award. In 2009 the ICREA-Academia Award for excellence in Biological and Medical Sciences

Research Interest

His research interests are protein folding, misfolding and amyloid formation, with special focus on their role in conformational diseases such as Alzheimer, Diabetes or Mitochondrial and Prionic disorders. The final goal is to understand the mechanism of protein homeostasis in the cell and how nature maintains the delicate balance between functional and pathogenic amyloids to generate novel biological functions and protect against disease in humans.



Global Speakers in the subject

Global Experts in the subject